Menu Close

Trending

Roche, Boehringer tap biosensor firms for patient studies
A new dawn of the genomic age: five areas set to be transformed in 2023
ABPI code updated with first social media guidance
NICE recommends first CAR-T cell therapy on NHS in England
EU clears Enhertu for HER2-low breast cancer

Orion corporation

Photo: Bayer AG

Market Access/ News/ News

MHRA, NHS England make available new prostate cancer treatment

, , , , , , , 0 Comment

Jointly Bayer and Orion Corporation-developed NUBEQA (Darolutamide) + Androgen Deprivation Therapy (ADT) in combination with docetaxel is to

X
MHRA, NHS England make available new prostate cancer treatment
https://pharmaphorum.com/news/mhra-nhs-england-make-available-new-prostate-cancer-treatment/

Login

CONTINUE TO SITE >
X
Close in 10 seconds